News

Efficacy and Safety of Kybella When Used Off-Label

Kybella Off-Label Uses Investigated

Calvin T. Sung MD, et al, of the University of California, Riverside School of Medicine and University of California, Irvine, Department of Dermatology, performed a systematic literature search through PubMed, Cochrane, CINAHL and Web of Science databases, to investigate the safety and efficacy of injectable deoxycholic acid (DCA; Kybella; Allergan) when used off-label to treat fat tissue in areas of the body other than the submental region.

Merz Americas Rhatigan Chosen as PharmaVOICE 100 Award Recipient

Merz CEO Honored

Bob Rhatigan, CEO of Merz Americas, has been named one of the top 100 most inspiring and influential life sciences leaders by PharmaVOICE magazine, a healthcare trade publication. The annual PharmaVOICE 100 awards recognize inspirational, motivational and transformative individuals in life sciences who positively impact their colleagues, peers, organizations and the industry.

Allergan Voluntarily Recalls BIOCELL Textured Breast Implants and Tissue Expanders

Allergan Recalls Textured Implants

Allergan has announced a voluntary worldwide recall of its BIOCELL textured breast implants and tissue expanders. The company said it is taking this action as a precaution following notification of recently updated global safety information concerning breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) provided by the U.S. Food and Drug Administration (FDA).

Cynosure Expands Body Contouring Technologies with TempSure Firm and SculpSure Petite Mask

Cynosure Expands Body Contouring Range

Hologic’s Cynosure division has launched two new applicators— the TempSure Firm handpiece and a petite mask for SculpSure submental treatments—to better serve the growing market for noninvasive body contouring and cellulite reduction treatments. The TempSure Firm is the latest addition to the TempSure platform, which delivers monopolar radiofrequency energy through massage heads to gently heat tissue and temporarily reduce the appearance of cellulite. The new 60mm handpiece allows practitioners to treat larger areas of the body at a faster rate, without surgery or downtime.

Chicago Cosmetic Surgery and Dermatology Joins Soliton Pivotal Cellulite Trial

Soliton, a medical device company with a novel and proprietary rapid pulse acoustic shockwave technology licensed from The University of Texas, has brought on supervising physicians Omer Ibrahim, MD, FAAD, and Carolyn I. Jacob, MD, FAAD, as well as a third study site for its upcoming expanded pivotal Cellulite Clinical Trial. The site, Chicago Cosmetic Surgery and Dermatology, joins two previously identified sites in what is anticipated to be a four-site trial.

String Grafts Effective for Scars and Established Wrinkles

New Alternative to Fillers and Fat

In the July issue of Plastic and Reconstructive Surgery, plastic surgeon Bahman Guyuron, MD, and resident Ji H. Son, MD, shared outcomes of a string fat/dermis graft procedure for depressed scars and established, recalcitrant rhytides and creases that they have performed in 39 patients (49 sites). The procedure involves harvesting a graft of dermis and fat in the shape of a string—approximately 1mm to 2mm thick—that matches the length of the depressed line or scar to be corrected.

Walker Named Chief Marketing Officer of SENTE

Adelle Walker is the new chief marketing officer (CMO) of SENTE, maker of heparan sulfate analog-based medical grade skincare. Walker brings more than 15 years experience in the dermatology and aesthetics industry to the position. She previously worked with Allergan, SkinMedica and Syneron Candela. As CMO of SENTE, she will take an executive leadership role in defining pipeline strategy as well as internal and external portfolio planning. Walker will also lead all communications from marketing to professional relations, education and consumer promotion.